Artwork

Content provided by Karen Jagoda. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Jagoda or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Developing Preventative Vaccines for Infectious Diseases with Thomas Lingelbach Valneva TRANSCRIPT

 
Share
 

Manage episode 243440920 series 99915
Content provided by Karen Jagoda. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Jagoda or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs. This biotech company is in development of a Lyme disease vaccine and vaccines for mosquito-borne illnesses such as Zika and chikungunya. Thomas talks about the challenges of testing vaccines to prevent a disease within a healthy population and why it is impossible to eliminate all the vectors that can transmit a disease.

@ValnevaSE

#Lyme #LymeDisease #chikungunya

Valneva.com

Listen to the podcast here

Additional links:

Chikungunya Fact Sheet

Lyme Fact Sheet

World Health Organization Zika virus resources

World Health Organization Japanese encephalitis resources

  continue reading

1733 episodes

Artwork
iconShare
 
Manage episode 243440920 series 99915
Content provided by Karen Jagoda. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Karen Jagoda or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs. This biotech company is in development of a Lyme disease vaccine and vaccines for mosquito-borne illnesses such as Zika and chikungunya. Thomas talks about the challenges of testing vaccines to prevent a disease within a healthy population and why it is impossible to eliminate all the vectors that can transmit a disease.

@ValnevaSE

#Lyme #LymeDisease #chikungunya

Valneva.com

Listen to the podcast here

Additional links:

Chikungunya Fact Sheet

Lyme Fact Sheet

World Health Organization Zika virus resources

World Health Organization Japanese encephalitis resources

  continue reading

1733 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide